Study of CRx-401 on Glucose Levels in Subjects With Type II Diabetes
NCT00506298
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
150
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes
Interventions
DRUG:
bezafibrate + diflunisal
DRUG:
bezafibrate + placebo
Sponsor
Zalicus